Newsgather

antiviral

Estable10 noticias6 fuentesÚltima actualización: hace 6 días

Últimas noticias

Unapproved Ovarian Cancer Blood Test Available in Australia Sparks Expert Concern
En desarrollo
Salud·hace 6 díasResumen IA

Unapproved Ovarian Cancer Blood Test Available in Australia Sparks Expert Concern

An "early detection blood test" for ovarian cancer is now available in Australia for $1,495, marketed by BCAL Diagnostics. Despite ads targeting all women, the company states it's for high-risk individuals. Experts warn the test is not TGA-approved, has limited data, and a significant false-positive rate, potentially causing distress and unnecessary costs.

G
Guardian Australia
4 min de lectura
Teksas'taki askeri üste grip salgını: Pentagon zorunlu aşıyı geri getirdi
En desarrollo
Defense·27/6/2026Resumen IA

Teksas'taki askeri üste grip salgını: Pentagon zorunlu aşıyı geri getirdi

ABD'nin Teksas eyaletindeki Lackland Hava Kuvvetleri Üssü'nde 275 askerin grip olması ve bir askerin hayatını kaybetmesi üzerine Pentagon, daha önce kaldırılan zorunlu grip aşısı uygulamasını yeniden başlattı. Savunma Bakanı Pete Hegseth'in iki ay önce gönüllü hale getirdiği aşı, salgının büyümesiyle tekrar zorunlu kılındı.

M
Milliyet Son Dakika
3 min de lectura
New Antiviral Drug Developed for Orthoparamyxoviruses
En desarrollo
Salud·24/5/2026Resumen IA

New Antiviral Drug Developed for Orthoparamyxoviruses

Researchers at Georgia State University have developed a new oral antiviral drug, GHB-85310, effective against orthoparamyxoviruses like measles and respiratory syncytial virus. The drug, taken once daily, shows high efficacy in animal models and human airway organ cultures, offering hope for treating these significant human health threats, especially for vulnerable populations.

ا
الشرق الأوسط
8 min de lectura